Céline Marie Elise Gossner

Dr. Céline Marie Elise Gossner

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Environmental Health Perspectives
Verified
Journal Article
Open access
CGCéline Marie Elise Gossner
Céline Marie Elise Gossner
Joergen SchlundtJoergen Schlundt
Joergen Schlundt
PEPeter Ben Embarek
Peter Ben Embarek
SHSusan Hird
Susan Hird
DLDanilo Lo-Fo-Wong
Danilo Lo-Fo-Wong
ATAngelika Tritscher
Angelika Tritscher
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

27 December 2014 in Zoonoses and Public Health
Verified
Journal Article
Open access
PDF file
CGCéline Marie Elise Gossner
Céline Marie Elise Gossner
NDN. Danielson
N. Danielson
AGA. Gervelmeyer
A. Gervelmeyer
FBF. Berthe
F. Berthe
BFB. Faye
B. Faye
DCD. Coulombier
D. Coulombier
Summary: Middle East respiratory syndrome coronavirus (MERS‐CoV) cases without documented contact with another human MERS‐CoV case make up 61% (517/853) of all reported cases. These primary cases are of particular interest for understanding the source(s) and route(s) of transmission and for designing long‐term disease control measures. Dromedary camels are the only animal species for which there is convincing evidence that it is a host species for MERS‐CoV and hence a potential source of human infections. However, only a small proportion of the primary cases have reported contact with camels. Other possible sources and vehicles of infection include food‐borne transmission through consumption of unpasteurized camel milk and raw meat, medicinal use of camel urine and zoonotic transmission from other species. There are critical knowledge gaps around this new disease which can only be closed through traditional field epidemiological investigations and studies designed to test hypothesis regarding sources of infection and risk factors for disease. Since the 1960s, there has been a radical change in dromedary camel farming practices in the Arabian Peninsula with an intensification of the production and a concentration of the production around cities. It is possible that the recent intensification of camel herding in the Arabian Peninsula has increased the virus' reproductive number and attack rate in camel herds while the ‘urbanization’ of camel herding increased the frequency of zoonotic ‘spillover’ infections from camels to humans. It is reasonable to assume, although difficult to measure, that the sensitivity of public health surveillance to detect previously unknown diseases is lower in East Africa than in Saudi Arabia and that sporadic human cases may have gone undetected there.

4 May 2017 in Eurosurveillance
Verified
Journal Article
Open access
CGCéline Marie Elise Gossner
Céline Marie Elise Gossner
LMLaurence Marrama
Laurence Marrama
MCMarianne Carson
Marianne Carson
FAFranz Allerberger
Franz Allerberger
Paolo  CalistriPaolo Calistri
Paolo Calistri
AGAndrea Gervelmeyer
Andrea Gervelmeyer
This article uses the experience of five European countries to review the integrated approaches (human, animal and vector) for surveillance and monitoring of West Nile virus (WNV) at national and European levels. The epidemiological situation of West Nile fever in Europe is heterogeneous. No model of surveillance and monitoring fits all, hence this article merely encourages countries to implement the integrated approach that meets their needs. Integration of surveillance and monitoring activities conducted by the public health authorities, the animal health authorities and the authorities in charge of vector surveillance and control should improve efficiency and save resources by implementing targeted measures. The creation of a formal interagency working group is identified as a crucial step towards integration. Blood safety is a key incentive for public health authorities to allocate sufficient resources for WNV surveillance, while the facts that an effective vaccine is available for horses and that most infected animals remain asymptomatic make the disease a lesser priority for animal health authorities. The examples described here can support other European countries wishing to strengthen their WNV surveillance or preparedness, and also serve as a model for surveillance and monitoring of other (vector-borne) zoonotic infections.

16 March 2023 in Eurosurveillance
Verified
Journal Article
Open access
JHJasper Van Heuverswyn
Jasper Van Heuverswyn
LHLuisa K. Hallmaier-Wacker
Luisa K. Hallmaier-Wacker
JBJulien Beauté
Julien Beauté
JDJoana Gomes Dias
Joana Gomes Dias
JHJoana M Haussig
Joana M Haussig
CGCéline Marie Elise Gossner
Céline Marie Elise Gossner
Background: Tick-borne encephalitis (TBE) is a vaccine-preventable disease involving the central nervous system. TBE became a notifiable disease on the EU/EEA level in 2012. Aim: We aimed to provide an updated epidemiological assessment of TBE in the EU/EEA, focusing on spatiotemporal changes. Methods: We performed a descriptive analysis of case characteristics, time and location using data of human TBE cases reported by EU/EEA countries to the European Centre for Disease Prevention and Control with disease onset in 2012–2020. We analysed data at EU/EEA, national, and subnational levels and calculated notification rates using Eurostat population data. Regression models were used for temporal analysis. Results: From 2012 to 2020, 19 countries reported 29,974 TBE cases, of which 24,629 (98.6%) were autochthonous. Czechia, Germany and Lithuania reported 52.9% of all cases. The highest notification rates were recorded in Lithuania, Latvia, and Estonia (16.2, 9.5 and 7.5 cases/100,000 population, respectively). Fifty regions from 10 countries, had a notification rate ≥ 5/100,000. There was an increasing trend in number of cases during the study period with an estimated 0.053 additional TBE cases every week. In 2020, 11.5% more TBE cases were reported than predicted based on data from 2016 to 2019. A geographical spread of cases was observed, particularly in regions situated north-west of known endemic regions. Conclusion: A close monitoring of ongoing changes to the TBE epidemiological situation in Europe can support the timely adaption of vaccination recommendations. Further analyses to identify populations and geographical areas where vaccination programmes can be of benefit are needed.

14 June 2018 in Eurosurveillance
Verified
Journal Article
Open access
CGCéline Marie Elise Gossner
Céline Marie Elise Gossner
EDEls Ducheyne
Els Ducheyne
FSFrancis Schaffner
Francis Schaffner
Autochthonous outbreaks of chikungunya and dengue during the past decade showed that continental Europe is vulnerable to Aedes albopictus–borne infections. Ae. albopictus has spread geographically, resulting in more people exposed to risk. Timely application of adequate mosquito suppression measures may delay, or even prevent, the vector population from crossing the potential epidemic abundance threshold should a pathogen be introduced. Health authorities should be on alert to detect early cases to prevent autochthonous outbreaks.

17 August 2023 in Eurosurveillance
Verified
Journal Article
Open access
GAGIORGIA ANGELONI
GIORGIA ANGELONI
Michela BertolaMichela Bertola
Michela Bertola
ELElena Lazzaro
Elena Lazzaro
MMMatteo Morini
Matteo Morini
GMGiulia Masi
Giulia Masi
Luisa BarzonLuisa Barzon
Luisa Barzon
Background: Usutu virus (USUV) is a flavivirus with an enzootic cycle between birds and mosquitoes; humans are incidental dead-end hosts. In Europe, the virus was first detected in Italy in 1996; since then, it has spread to many European countries. Aim: We aimed to report on the epidemiology, surveillance, diagnosis and prevention of USUV infection in humans, mosquitoes and other animals in the European Union/European Economic Area (EU/EEA) from 2012 to 2021. Methods: We collected information through a literature review, an online survey and an expert meeting. Results: Eight countries reported USUV infection in humans (105 cases, including 12* with neurological symptoms), 15 countries in birds and seven in mosquitoes. Infected animals were also found among pets, wild and zoo animals. Usutu virus was detected primarily in Culex pipiens but also in six other mosquito species. Detection of USUV infection in humans is notifiable only in Italy, where it is under surveillance since 2017 and now integrated with surveillance in animals in a One Health approach. Several countries include USUV infection in the differential diagnosis of viral encephalitis and arbovirus infections. Animal USUV infection is not notifiable in any EU/EEA country. Conclusion: Human USUV infections, mainly asymptomatic and, less frequently, with a febrile illness or a neuroinvasive disease, have been reported in several EU/EEA countries, where the virus is endemic. Climate and environmental changes are expected to affect the epidemiology of USUV. A One Health approach could improve the monitoring of its evolution in Europe.